Yankelove Samuel J MD is categorized under Ophthalmologists in Houston, TX and active since 1976.
Yankelove Samuel J MD was established in 1976, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Samuel Yankelove at the company’s single location by writing to 8800 Katy Freeway # 107, Houston, Texas TX 77024 or by phoning (713) 827-8311. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Yankelove Samuel J MD |
| Contact Person: | Samuel Yankelove |
| Address: | 8800 Katy Freeway # 107, Houston, Texas 77024 |
| Phone Number: | (713) 827-8311 |
| Website Address: | eyelaserspecialists.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1976 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Yankelove Samuel J MD was started in 1976 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Samuel Yankelove for inquiries that concern Yankelove Samuel J MD by calling the company number (713) 827-8311, as your correspondence is most welcome. Additionally, the physical location of the single location of Yankelove Samuel J MD can be found at the coordinates 29.78395,-95.50697 as well as the street address 8800 Katy Freeway # 107 in Houston, Texas 77024.
For its online presence, you may visit Yankelove Samuel J MD’s website at eyelaserspecialists.com and engage with its social media outlets through on Twitter and on Facebook.